Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Hereditary spherocytosis

Haematology and transfusion · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Severe pallor, tachycardia, syncope or heart failure after a viral illness may represent an aplastic crisis; obtain an urgent full blood count and reticulocyte count, cross-match blood and involve haematology. Fever in a splenectomised patient is a separate sepsis emergency requiring immediate assessment and protocol antibiotics, regardless of vaccination history.

Synopsis

Recognise membrane-related extravascular haemolysis, confirm the phenotype without over-interpreting a single screening assay, manage anaemia and gallstones, and plan splenectomy and infection prevention safely.

  • Hereditary spherocytosis is an inherited red-cell membrane disorder causing poorly deformable spherocytes to be trapped and destroyed in the spleen.
  • Anaemia, jaundice, splenomegaly, reticulocytosis and pigment gallstones vary from an incidental compensated phenotype to transfusion-dependent disease in infancy.
  • A blood film may show dense spherocytes without central pallor, but autoimmune haemolysis also produces spherocytes and must be separated with a direct antiglobulin test.
  • Raised mean corpuscular haemoglobin concentration, unconjugated bilirubin and lactate dehydrogenase with low haptoglobin support haemolysis; indices can be subtle between crises.
  • Eosin-5-maleimide binding by flow cytometry is a useful confirmatory membrane test in most UK specialist laboratories; equivocal cases may need additional testing or genomic analysis.
  • Parvovirus B19 can abruptly suppress reticulocytes, producing a disproportionate haemoglobin fall and sometimes affecting several members of a household.
  • Folate is used when erythropoietic demand is substantial, while red-cell transfusion is reserved for symptomatic or severe anaemia rather than a habitual haemoglobin number alone.
  • Splenectomy improves haemolysis but does not correct the membrane defect; timing weighs disease burden against lifelong overwhelming infection and thrombotic risk.
  • Before elective splenectomy, address pneumococcal, meningococcal and influenza vaccination, antibiotic prophylaxis, fever action planning and a patient-held alert.
  • Persistent abdominal pain or cholestatic jaundice warrants gallstone and biliary assessment, particularly in adolescents and adults with longstanding haemolysis.

Key red flags

Aplastic crisis

A sudden profound anaemia with an unexpectedly low reticulocyte count after fever or rash requires urgent haematology assessment.

Investigation priorities

01
Full blood count and reticulocytesFirst step

Quantify anaemia and marrow compensation.

Management branches

Diagnostic routeConfirm inherited haemolysis

Anaemia, jaundice or splenomegaly occurs with spherocytes or a family history.

  1. Obtain blood count, reticulocytes, film, bilirubin, LDH and haptoglobin, documenting transfusion timing and the clinical family pedigree.
  2. Perform a direct antiglobulin test before attributing spherocytes to inheritance, then request eosin-5-maleimide testing through haematology when the phenotype remains compatible.
  3. Use broader membrane, enzyme or genomic testing for atypical, severe, transfused or equivocal cases and offer family counselling around the confirmed result.
Acute deteriorationSeparate haemolytic from aplastic change

A person with stable disease develops abrupt pallor, breathlessness, fever or worsening jaundice.

  1. Assess haemodynamics and cardiac symptoms, repeat haemoglobin and reticulocytes urgently and send group-and-save or cross-match where compromise is possible.
  2. A high reticulocyte response with bilirubin rise suggests accelerated haemolysis, whereas a low response prompts parvovirus testing and infection precautions in vulnerable contacts.
  3. Transfuse for clinically important anaemia under haematology and transfusion guidance, reassessing symptoms and avoiding an automatic chronic threshold.

Key medicines

Folic acidHaematology commonly prescribes 5 mg orally once daily when haemolysis is moderate or severe, during pregnancy or when dietary folate may not meet erythropoietic demand.Confirm the indication and consider vitamin B12 status before prolonged treatment; mild compensated disease may not require continuous supplementation.
Phenoxymethylpenicillin after splenectomyA common adult regimen is 250 mg orally twice daily. Start after splenectomy, follow the current asplenia policy for duration and allergy alternatives, and continue lifelong when invasive pneumococcal risk remains high.Check immediate penicillin allergy, adherence and local resistance advice. Prophylaxis and vaccination do not make fever safe to observe at home; provide an emergency antibiotic and assessment plan plus travel and animal-bite advice.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • British Society for Haematology hereditary spherocytosis guidelineDiagnostic testing, severity assessment, splenectomy and supportive management.
  • Genomics Education hereditary spherocytosis resourceInheritance, membrane biology, genomic testing and family implications.
  • UKHSA Green Book immunisation guidanceVaccination schedules and risk-group advice for absent or dysfunctional spleen.
  • NICE blood transfusion recommendationsUK red-cell prescribing, reassessment and patient blood-management principles.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom